This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreRoyalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million
USFDA Grants Fast-Track Nod to Boehringer Ingelheims Zongertinib for Rare Lung CancerBoehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant...
Dr Reddys Labs CHRO Archana Bhaskar resignsDr Reddy's Labs CHRO Archana Bhaskar resigns
Lupin Secures USFDA Nod for Epilepsy Drug Brivaracetam in USLupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made...
Minister calls for strong focus on RnD to produce affordable, high-quality medical devicesMinister calls for strong focus on RnD to produce affordable, high-quality medical devices
Paracetamol Market 2025: DOLO-650 the Top Prescribed brand, suggests industry dataParacetamol Market 2025: DOLO-650 the Top Prescribed brand, suggests industry data
Factory manufacturing banned oxytocin injections busted in Lucknow, 4 arrestedFactory manufacturing banned oxytocin injections busted in Lucknow, 4 arrested
After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid FormulationsCDSCO Panel Allows Ravenbhel to Conduct BE, Phase III Trial of Dapagliflozin, Sacubitril, Valsartan...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca eyes year-end filing for BP drug Baxdrostat
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCOOne Death a Day: 1,705 Lives Lost in India's Clinical Trials Since 2021, RTI Reveals
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Faces Setback as CDSCO Panel Rejects Seloken XL Prescribing Update
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealAbbott Dissolving Stent receives CE Mark in Europe for peripheral artery disease
X